Skip to main content

Table 2 Reasons why survey responders did or did not conduct a risk assessment prior to developing the monitoring plan

From: Perceived barriers and facilitators to Risk Based Monitoring in academic-led clinical trials: a mixed methods study

Participants who did conduct a risk assessment (n = 50)

%

Participants who did not conduct a risk assessment (n = 35)

%

Facilitators

Barriers

To improve patient safety

43 (86%)

Question not relevant, developing monitoring plan is a sponsor duty

15 (43%)

To improve data accuracy

32 (64%)

It is not a GCP requirement

7 (20%)

To fulfil GCP requirements

29 (58%)

Do not have the expertise to perform a risk assessment

6 (17%)

To determine a schedule for on-site monitoring visits

21 (42%)

It is too time consuming

6 (17%)

To fulfil HPRA/IMB requirements

20 (40%)

It will not improve patient safety

2 (6%)

To reduce monitoring costs

8 (16%)

It is too expensive

1 (3%)

  1. GCP Good Clinical Practice, HPRA Health Protection Regulatory Authorities, IMB Irish Medicines Board